Answers are grounded in this paper and cite their sources.
AIMS: To determine the incidence of neonatal thromboembolism in Germany. METHODS: Diagnostic imaging techniques, therapeutic modalities, and short term outcome were evaluated in a prospective nationwide two year case registry study. RESULTS: The reported incidence of symptomatic neonatal thromboembolism, diagnosed in most cases with Doppler ultrasonography, was 5.1 per 100000 births, with a total of 79 cases registered: renal venous thrombosis (n = 35); venous thrombosis (n = 25); and arterial vascular occlusion (n = 19). Fifty seven of 79 thromboses were associated with additional risk factors (central line n = 25, asphyxia n = 13, septicaemia n = 11, dehydration n = 6, maternal diabetes n = 2, cardiac disease n = 1). Inherited thrombophilia was also diagnosed in seven out of 35 cases investigated. Twenty three children received supportive treatment: 42 received heparin and in 13 neonates thrombolytic agents were administered. Most neonates (91%) survived; seven died. CONCLUSION: Controlled multicentre studies are needed to obtain more information on treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Nowak‐Göttl et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: